bunazosin has been researched along with timolol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Nasa, Y; Takeo, S; Yabe, K | 1 |
| Araie, M; Koide, T; Mizuno, K; Yoshimura, M | 1 |
| Iizuka, Y; Kashiwagi, K; Tsukahara, S | 1 |
| Akaishi, T; Hara, H; Kuwayama, Y; Matsugi, T; Miyawaki, N; Shimazaki, A | 1 |
| Kobayashi, H; Kobayashi, K; Okinami, S | 1 |
| Higuchi, S; Kawazu, K; Kitahara, T; Nakamura, J; Nakashima, M; Nishida, K; Sakanaka, K; Sasaki, H; Tomonari, M | 1 |
1 trial(s) available for bunazosin and timolol
| Article | Year |
|---|---|
Efficacy of bunazosin hydrochloride 0.01% as adjunctive therapy of latanoprost or timolol.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Pupil; Quinazolines; Timolol | 2004 |
6 other study(ies) available for bunazosin and timolol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Beta-adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Creatine Kinase; Heart; Heart Rate; Isoproterenol; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Norepinephrine; Phenylephrine; Quinazolines; Random Allocation; Rats; Rats, Sprague-Dawley; Timolol; Ventricular Function, Left | 1997 |
Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood-Retinal Barrier; Cell Count; Dose-Response Relationship, Drug; Drug Combinations; Male; N-Methylaspartate; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Propanolamines; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Retina; Retinal Artery; Timolol; Vasoconstriction | 2001 |
Neuroprotective effects of nipradilol on purified cultured retinal ganglion cells.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Antihypertensive Agents; Cell Separation; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Cyclic N-Oxides; Dose-Response Relationship, Drug; Flow Cytometry; Imidazoles; Neuroprotective Agents; Nitric Oxide; Propanolamines; Quinazolines; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Timolol | 2002 |
[Effects of ocular hypotensive agents on the circadian rhythm in intraocular pressure in rabbits as measured by telemetry].
Topics: Animals; Circadian Rhythm; Intraocular Pressure; Male; Quinazolines; Rabbits; Sulfonamides; Telemetry; Thiophenes; Timolol | 2003 |
Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Algorithms; Animals; Aqueous Humor; Drug Combinations; Glaucoma; Intraocular Pressure; Male; Models, Statistical; Ocular Hypertension; Ophthalmic Solutions; Quinazolines; Rabbits; Telemetry; Timolol | 2008 |